|
Report Date : |
15.01.2014 |
IDENTIFICATION DETAILS
|
Name : |
LABORATORIOS EUROMED CHILE S.A. |
|
|
|
|
Registered Office : |
Camino a Melipilla 7073, Santiago, XIII Región Metropolitana |
|
|
|
|
Country : |
Chile |
|
|
|
|
Date of Incorporation : |
14.05.1988 |
|
|
|
|
Legal Form : |
Joint-Stock Company |
|
|
|
|
Line of Business : |
Manufacture, distribution and sale of generic medicines and own
pharmaceutical specialties. |
|
|
|
|
No. of Employees : |
Not Available |
RATING & COMMENTS
|
MIRA’s Rating : |
B |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
Status : |
Moderate |
|
Payment Behaviour : |
No complaints |
|
Litigation : |
Clear |
NOTES :
Any query related to this report can be made
on e-mail : infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – September 30, 2013
|
Country Name |
Previous Rating (30.06.2013) |
Current Rating (30.09.2013) |
|
Chile |
A2 |
A2 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
CHILE - ECONOMIC OVERVIEW
Chile has a market-oriented economy characterized by a high level of foreign trade and a reputation for strong financial institutions and sound policy that have given it the strongest sovereign bond rating in South America. Exports account for approximately one-third of GDP, with commodities making up some three-quarters of total exports. Copper alone provides 19% of government revenue. From 2003 through 2012, real growth averaged almost 5% per year, despite the slight contraction in 2009 that resulted from the global financial crisis. Chile deepened its longstanding commitment to trade liberalization with the signing of a free trade agreement with the US, which took effect on 1 January 2004. Chile has 22 trade agreements covering 60 countries including agreements with the European Union, Mercosur, China, India, South Korea, and Mexico. Chile has joined the United States and nine other countries in negotiating the Trans-Pacific-Partnership trade agreement. In 2012, foreign direct investment inflows reached $28.2 billion, an increase of 63% over the previous record set in 2011. The Chilean Government has generally followed a countercyclical fiscal policy, accumulating surpluses in sovereign wealth funds during periods of high copper prices and economic growth, and generally allowing deficit spending only during periods of low copper prices and growth. As of 31 December 2012, those sovereign wealth funds - kept mostly outside the country and separate from Central Bank reserves - amounted to more than $20.9 billion. Chile used these funds to finance fiscal stimulus packages during the 2009 economic downturn. In May 2010 Chile signed the OECD Convention, becoming the first South American country to join the OECD.
|
Source
: CIA |
|
CORRECT COMPANY NAME |
LABORATORIOS EUROMED CHILE S.A. |
|
TAXPAYER REGISTRATION |
RUT 798027700 |
|
MAIN ADDRESS |
Camino a Melipilla 7073, Santiago |
|
DEPT/PROV/REGION/STATE |
XIII Región Metropolitana |
|
COUNTRY |
CHILE |
|
TELEPHONE |
(562) 24831500 |
|
CORPORATE E-MAIL |
violeta.labarca@labeuromed.cl |
|
WEB |
www.volta.cl |
|
COMMENTS |
|
|
The order was requested as LABORATORIO VOLTA S.A, it is clarified that
changed its name to the current LABORATORIOS EUROMED CHILE S.A. |
|
|
Date of foundation |
1988 |
|
Capital stock |
Ps$3,626,950,839.= Pesos |
|
Chief Executive |
ROIZMAN LEYDE, ROBERTO ARIE |
|
Disposition |
REPORT PREPARED FROM OUTSIDE SOURCES. |
|
Payments policy |
Usually to terms / good |
|
Number of times that this company was required: 2 |
|
|
LEGAL STATUS |
Joint-Stock Company |
|
|
|
DATE OF INCORPORATION |
14MAY1988 |
|
|
|
PLACE OF REGISTRY |
Santiago |
|
|
|
REGISTRATION |
5565, Page 10558 |
|
|
|
CURRENT PAID-IN CAPITAL |
Ps$3,626,950,839.= Pesos |
|
|
|
CURRENT EXCHANGE RATE (US$) |
Ps$529.89 per 1.00 US Dollar |
|
|
|
COMMENTS |
|
||
|
It was initially established as LABORATORIO VOLTA S.A. and on
06/06/2012 adopts the current name of LABORATORIOS EUROMED CHILE S.A. |
|||
|
|
|
ROIZMAN LEYDE, ROBERTO ARIE |
|||||||||
|
TITLE |
General Manager |
||||||||
|
NATIONALITY |
Chilean |
||||||||
|
PROFESSION |
Commercial Engineer |
||||||||
|
BACKGROUND INFORMATION |
Commercial engineer, major in Business Administration, from University
of Santiago de Chile and is currently taking the Executive MBA from
Universidad Adolfo Ibáñez. He has over 8 years of experience in pharmaceutical companies. He is a
member and General Manager of Laboratorio Volta SA. He is also a Partner and Director of
Farmindustria S.A. (formerly Schering-Plough), the main laboratory in
assembling-line drugs in Chile. He is a partner and member of the Advisory
Board of e-learning Seaprende (www.seaprende.com). His area of interest is
especially biotechnology; for this reason, Regen Chile has been recently
founded in order to represent and trade pharmaceuticals from biotechnology
and genetics companies around the world. Joined CEO in the first half of 2002. CEO is a nonprofit initiative of
people from private and public sectors, connected to the Internet industry
that is looking for a climate of organized endeavor in Chile. |
||||||||
|
|
|
||||||||
|
ASSOCIATED AS PER OUR DATABASE TO |
|||||||||
|
|||||||||
|
|
|
SIC Classification 2 8 - CHEMICALS, PHARMACEUTICALS INDUSTRY AND ALLIED PRODUCTS. (Manuf.
Pigments, Resins, Plastics, Serums, Perfums, Paints, Fertilizers, Explosives.
Medicines.) |
|||||||||||||
|
Main activity |
Manufacture, distribution and sale of generic medicines and own
pharmaceutical specialties. Representation of prestigious international companies manufacturers of
pharmaceutical specialties and medical supplies. Logistics service to the pharmaceutical industry Services of promotion and introduction of pharmaceutical products in
the national market. Brands carried: ABBOTT", "CHEMINOVA",
"CHATTEM", "TERUMO", "VITALIS",
"CAPSUGEL", "GENOMMA", "SUPERMAX" |
||||||||||||
|
O P E R A T I O N S |
|||||||||||||
|
Import |
Yes |
||||||||||||
|
Country |
India, China, Mexico |
||||||||||||
|
ANNUAL Imports In US$ (CIF) |
|
||||||||||||
|
Export |
No |
||||||||||||
|
SELLING TerritorY |
Domestic market |
||||||||||||
|
|||||||||||||
|
Disposition |
REPORT PREPARED FROM OUTSIDE SOURCES. |
|
Interviewee(s) |
Fuentes Externas |
|
Information provided |
This report has been compiled through third-party sources such as
databases and official because of the secrecy of the executive of the company
in providing information. |
|
|
|
|
|
|
|
SALES |
US$ 0.00 () |
|
FINANCIAL SITUATION |
FAIR In commercial media do not arise negative history against it. |
(Confidential Information)
|
TRADE REFERENCES |
||||||||||
|
|
|||||||||
|
Note : Other suppliers did not provide information or could not be
consulted |
|
|||||||||
|
|
|||||||||
|
|
|
|||||||||
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.61.52 |
|
|
1 |
Rs.101.48 |
|
Euro |
1 |
Rs.84.11 |
INFORMATION DETAILS
|
Report Prepared
by : |
NNA |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome
financial difficulties seems comparatively below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
---- |
NB |
New Business |
---- |
This score serves as a reference to assess SC’s credit risk and
to set the amount of credit to be extended. It is calculated from a composite
of weighted scores obtained from each of the major sections of this report. The
assessed factors and their relative weights (as indicated through %) are as
follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.